Top Markets
#1 DogBull DogBull +108.35%
#2 Siacoin Siacoin +65.57%
#3 MarsCoin MarsCoin +60.29%
#4 ADO Protocol ADO Protocol +48.14%
#5 The Bitcoin Bull The Bitcoin Bull +32.08%
#6 Ontology Gas Ontology Gas +20.47%
#7 AI XOVIA AI XOVIA +14.11%
#8 Arowana Arowana +12.43%
#9 UnifAI Network UnifAI Network +12.02%
#10 Akedo Akedo +11.67%
Coin of the day
DogBull DogBull
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
VectivBio Holding AG VectivBio Holding AG

VectivBio Holding AG

VECT
Clasificación en acciones #14767
VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to... VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to identifying, developing, and commercializing treatments for severe rare medical conditions. The company's primary therapeutic focus is apraglutide, a prolonged-acting synthetic peptide analog of glucagon-like peptide-2. This compound is currently in a Phase III clinical trial for individuals with short bowel syndrome-intestinal failure (SBS-IF), and is also being evaluated in a Phase II clinical trial for SBS-IF patients with colon-in-continuity anatomy. Furthermore, apraglutide is undergoing a Phase II clinical study for patients experiencing steroid-refractory gastrointestinal acute graft-versus-host disease (aGvHD). Founded in 2019, VectivBio's corporate headquarters are situated in Basel, Switzerland.
Precio por acción
$16.85
Última sincronización: 2023-07-07
Capitalización bursátil
$393.50M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CH
Comercio VectivBio Holding AG (VECT)

Categoría

Healthcare
Ratio P/B de VectivBio Holding AG (VECT)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de VectivBio Holding AG, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de VectivBio Holding AG desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.828 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.5116 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9942 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.2199 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH